CLINICAL_TRIALS
research
· 2026-02-13
Clinical Trial Update: Outcome in Patients Treated With Endovascular Thrombectomy - optIMAL Blood Pressure Control 2 (OPTIMAL-BP 2) [Phase 3]
Summary
Phase 3 trial OPTIMAL-BP 2 is currently recruiting to evaluate optimized blood pressure management after endovascular thrombectomy in acute ischemic stroke.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Yonsei University | Conditions: Acute Ischemic Stroke | Phase 3 | Status: RECRUITING